Calix[4]arènes chiraux contenant des groupes phosphine comme ligands pour la catalyse

The thesis is devoted to the developing of effective methods for the synthesis of new class of inherently chiral phosphorus-containing calix[4]arenes, phosphines and phosphoric acids with a certain mutual arrangement of functional groups on the lower rim of the macrocycle, with potential catalytic activity. The optimal way fot the synthesis of phosphorus-containing calix[4]arenes by the stepwise substitution of the phenolic hydroxyls was developed in order to design inherently chiral calix[4]arenes with ABHH and ABCH replacement types at the lower rim of the macrocycle. By using these techniques, synthesis of six analogues of known and effective catalysts with planar chirality was performed. Using X-ray diffraction studies allowed to investigate spatial location of functional groups. Using of Mitsunobu reaction allowed to provide synthesis of the new "pocket"-like ligands - calix[4]arenes bearing chiral ferrocenyl-phosphines moieties. The effectiveness of the synthesized new phosphine ligands was confirmed by the example of the model Tsuji-Trost reaction. Interesting dependence of the selectivity level on the metal cation size of added base, due to chelation effect of supramolecular ligand was observed. Calix[4]arenes phosphoric acids was first applied as organocatalysts the series of model reactions: aza-Diels-Alder reaction, aza-Mukaiyama asymmetric reaction and epoxides ring opening reaction. It was found that most of the synthesized compounds exhibit a noticeable level of catalytic activitydue to features of internal chirality.La thèse est consacrée à la développement de méthodes efficaces pour la synthèse d'une nouvelle classe d'intrinsèquement chiral calix[4]arènes contenant du phosphore, phosphines et acides phosphoriques avec une certaine disposition mutuelle des groupes fonctionnels sur le bord inférieur du macrocycle, avec un potentiel activité catalytique. La façon optimale fot la synthèse de calix[4]arènes contenant du phosphore par la substitution progressive des hydroxyles phénoliques a été développé afin de concevoir des intrinsèquement chiral calix[4]arènes avec des types de remplacement ABHH et ABCH au bord inférieur du macrocycle. En utilisant ces techniques, la synthèse de la six catalyseurs et efficaces avec chiralité planaire a été réalisée. En utilisant des études de diffraction des rayons X a permis d'étudier la localisation spatiale des groupes fonctionnels. L'utilisation de la réaction de Mitsunobu autorisé à fournir une synthèse de la nouvelle "poche" -comme ligands - calix[4]arènes portant des fragments ferrocényle-phosphines chirales. L'efficacité des nouveaux ligands phosphine synthétisés a été confirmé par l'exemple du modèle de réaction Tsuji-Trost. intéressante dépendance du niveau de sélectivité de la taille du cation de métal de base ajoutée, en raison de l'effet de ligand de chélation du supramoléculaire a été observée. Calix[4]arènes acides phosphoriques a d'abord été appliqués comme organocatalyseurs la série de réactions modèles: aza-Diels-Alder, aza-Mukayiama réaction asymétrique et réaction d'ouverture d'époxydes anneau. Il a été constaté que la plupart des composés synthétisés présentent un degré notable de activitydue catalytique à des caractéristiques de chiralité interne

Chiral phosphorus containing calix[4]arenes for asymmetric catalysis

La thèse est consacrée à la développement de méthodes efficaces pour la synthèse d'une nouvelle classe d'intrinsèquement chiral calix[4]arènes contenant du phosphore, phosphines et acides phosphoriques avec une certaine disposition mutuelle des groupes fonctionnels sur le bord inférieur du macrocycle, avec un potentiel activité catalytique. La façon optimale fot la synthèse de calix[4]arènes contenant du phosphore par la substitution progressive des hydroxyles phénoliques a été développé afin de concevoir des intrinsèquement chiral calix[4]arènes avec des types de remplacement ABHH et ABCH au bord inférieur du macrocycle. En utilisant ces techniques, la synthèse de la six catalyseurs et efficaces avec chiralité planaire a été réalisée. En utilisant des études de diffraction des rayons X a permis d'étudier la localisation spatiale des groupes fonctionnels. L'utilisation de la réaction de Mitsunobu autorisé à fournir une synthèse de la nouvelle "poche" -comme ligands - calix[4]arènes portant des fragments ferrocényle-phosphines chirales. L'efficacité des nouveaux ligands phosphine synthétisés a été confirmé par l'exemple du modèle de réaction Tsuji-Trost. intéressante dépendance du niveau de sélectivité de la taille du cation de métal de base ajoutée, en raison de l'effet de ligand de chélation du supramoléculaire a été observée. Calix[4]arènes acides phosphoriques a d'abord été appliqués comme organocatalyseurs la série de réactions modèles: aza-Diels-Alder, aza-Mukayiama réaction asymétrique et réaction d'ouverture d'époxydes anneau. Il a été constaté que la plupart des composés synthétisés présentent un degré notable de activitydue catalytique à des caractéristiques de chiralité interne.The thesis is devoted to the developing of effective methods for the synthesis of new class of inherently chiral phosphorus-containing calix[4]arenes, phosphines and phosphoric acids with a certain mutual arrangement of functional groups on the lower rim of the macrocycle, with potential catalytic activity. The optimal way fot the synthesis of phosphorus-containing calix[4]arenes by the stepwise substitution of the phenolic hydroxyls was developed in order to design inherently chiral calix[4]arenes with ABHH and ABCH replacement types at the lower rim of the macrocycle. By using these techniques, synthesis of six analogues of known and effective catalysts with planar chirality was performed. Using X-ray diffraction studies allowed to investigate spatial location of functional groups. Using of Mitsunobu reaction allowed to provide synthesis of the new "pocket"-like ligands - calix[4]arenes bearing chiral ferrocenyl-phosphines moieties. The effectiveness of the synthesized new phosphine ligands was confirmed by the example of the model Tsuji-Trost reaction. Interesting dependence of the selectivity level on the metal cation size of added base, due to chelation effect of supramolecular ligand was observed. Calix[4]arenes phosphoric acids was first applied as organocatalysts the series of model reactions: aza-Diels-Alder reaction, aza-Mukaiyama asymmetric reaction and epoxides ring opening reaction. It was found that most of the synthesized compounds exhibit a noticeable level of catalytic activitydue to features of internal chirality

New ferrocene derivatives for ligand grafting

International audienc

Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs

International audienceThere are several routes of administration to the brain, including intraparenchymal, intraventricular, and subarachnoid injections. The blood-brain barrier (BBB) impedes the permeation and access of most drugs to the central nervous system (CNS), and consequently, many neurological diseases remain undertreated. For past decades, to circumvent this effect, several nanocarriers have been developed to deliver drugs to the brain. Importantly, intranasal (IN) administration can allow direct delivery of drugs into the brain through the anatomical connection between the nasal cavity and brain without crossing the BBB. In this regard, dendrimers may possess great potential to deliver drugs to the brain by IN administration, bypassing the BBB and reducing systemic exposure and side effects, to treat diseases of the CNS. In this original concise review, we highlighted the few examples advocated regarding the use of dendrimers to deliver CNS drugs directly via IN. This review highlighed the few examples of the association of dendrimer encapsulating drugs (e.g., small compounds: haloperidol and paeonol; macromolecular compounds: dextran, insulin and calcitonin; and siRNA) using IN administration. Good efficiencies were observed. In addition, we will present the in vivo effects of PAMAM dendrimers after IN administration, globally, showing no general toxicity

Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity

International audienceThe novel human coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has caused a pandemic. There are currently several marketed vaccines and many in clinical trials targeting SARS-CoV-2. Another strategy is to repurpose approved drugs to decrease the burden of the COVID-19 (official name for the coronavirus disease) pandemic. as the FDA (U.S. Food and Drug Administration) approved antiviral drugs and anti-inflammatory drugs to arrest the cytokine storm, inducing the production of pro-inflammatory cytokines. Another view to solve these unprecedented challenges is to analyze the diverse nanotechnological approaches which are able to improve the COVID-19 pandemic. In this original minireview, as promising candidates we analyze the opportunity to develop biocompatible dendrimers as drugs themselves or as nanocarriers against COVID-19 disease. From the standpoint of COVID-19, we suggest developing dendrimers as shields against COVID-19 infection based on their capacity to be incorporated in several environments outside the patients and as important means to stop transmission of SARS-CoV-2

Organocatalytic Michael Addition as a Method for Polyisobutylene Chain‐End Functionalization

International audienc

Well-Defined P III -Terminated Polymers from Phosphorylated Carbodithioate RAFT Agents

International audienceFive S-alkyl di-tert-butylphosphorylated carbodithioates, Z–C(S)SR, were studied as chain transfer agents (CTAs) in the RAFT polymerization of vinyl monomers. These phosphorus-containing CTAs involve new PIII and PV moieties in the Z group (phosphine-borane or free phosphine). Two of them, with an S-bonded 1-methoxycarbonylethyl group as leaving group, have not previously been described. The CTAs with a PV Z group provide good control over the polymerization of styrene (St) and n-butyl acrylate (nBA). Molar masses are close to theoretical values, and dispersities are consistently low during polymerization. The monitoring of polymerization by 31P NMR spectroscopy supports the controlled character and the integrity of the polymer chain ends. Conversely, they inhibit the polymerization of the less-activated monomer vinyl acetate (VAc). The reactivity of the CTAs with a PIII Z group mainly depends on the reaction medium, and their performance for St, nBA, and VAc was surprising and unexpected. Theoretical calculations were carried out to rationalize their behavior. Finally, an innovative strategy was developed to obtain well-controlled polymers with free phosphine ω-chain ends

Synthesis of S-Alkyl Phosphinocarbodithioates with Switch between P(III) and P(V) Derivatives

International audienceSimple and effective synthetic pathways are described to prepare compounds R2P(X)C(S)SCH(Me)Ph with the P atom either in the oxidation state V [R/X = t-Bu/O (6), Ph/S, (7), t-Bu/S (8), t-Bu/Se (9)] or III [R/X = Ph/BH3 (4), t-Bu/BH3 (5), t-Bu/lone pair (10)]. Compound 9 is the first example of carbodithioate ester with a P=Se group and for the first time a phosphinocarboditioate with a free phosphine function (compound 10) is described. Stabilization of the latter crucially depends on the steric protection by the t-Bu groups, since an analogous derivative with R = Ph is observable but too unstable for isolation. Compound 10 can be reversibly protonated to yield the [t-Bu2PHC(S)SCH(Me)Ph] + cation (10-H +), which was isolated as a BF4-salt. A few interconversion processes resulting in the facile addition/removal or exchange of the X group in this family of compounds are also described. The phosphorus atom oxidation state and the nature of electron-withdrawing group have a significant impact on the spectral properties

First-in-class and best-in-class dendrimer nanoplatforms from concept to clinic: Lessons learned moving forward

International audienceResearch to develop active dendrimers by themselves or as nanocarriers represents a promising approach to discover new biologically active entities that can be used to tackle unmet medical needs including difficult diseases. These developments are possible due to the exceptional physicochemical properties of dendrimers, including their biocompatibility, as well as their therapeutic activity as nanocarriers and drugs themselves. Despite a large number of academic studies, very few dendrimers have crossed the ‘valley of death’ between. Only a few number of pharmaceutical companies have succeeded in this way. In fact, only Starpharma (Australia) and Orpheris, Inc. (USA), an Ashvattha Therapeutics subsidiary, can fill all the clinic requirements to have in the market dendrimers based drugs/nancocarriers. After evaluating the main physicochemical properties related to the respective biological activity of dendrimers classified as first-in-class or best-in-class in nanomedicine, this original review analyzes the advantages and disavantages of these two strategies as well the concerns to step in clinical phases. Various solutions are proposed to advance the use of dendrimers in human health

Clinical diagonal translation of nanoparticles: Case studies in dendrimer nanomedicine

International audienceAmong the numerous nanomedicine formulations, dendrimers have emerged as original, efficient, carefully assembled, hyperbranched, polymeric nanoparticles based on synthetic monomers. Dendrimers are used either as nanocarriers of drugs or as drugs themselves. When used as drug carriers, dendrimers are considered ‘best-in-class agents’, modifying and enhancing the pharmacokinetic and pharmacodynamic properties of the active entities encapsulated or conjugated with the dendrimers. When used as drugs themselves, dendrimers represent a novel category of “first-in-class” drugs. The purpose of this original review is to analyse the different strategies involved in the development, application, and impact of dendrimers as drugs. We examine a selection of nanoparticles that use multifunctional elements and demonstrate clinical multifunctionality, and we extend these principles to applications in dendrimer nanomedicine design. Finally, for practical consideration, the concepts of vertical and diagonal translation are introduced as potential strategies to facilitate dendrimer development